Low Immunogenicity in Patients with Giant Cell Arteritis Treated with Tocilizumab: 3-Year Results from the Randomized Controlled Portion and the Open-Label Follow-Up of a Phase 3 Trial

被引：0
|
作者：
Stone, John H. [1 ]
Mallalieu, Navita L. [2 ]
Bao, Min [3 ]
机构：
[1] Harvard Med Sch, Massachusetts Gen Hosp, Rheumatol Unit, Boston, MA 02115 USA
[2] Roche Innovat Ctr, New York, NY USA
[3] Genentech Inc, San Francisco, CA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1924
引用
收藏
页数：3
相关论文
共 50 条
  • [1] LOW IMMUNOGENICITY IN PATIENTS WITH GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB: 3-YEAR RESULTS FROM THE RANDOMIZED CONTROLLED PORTION AND OPEN-LABEL FOLLOW-UP OF A PHASE 3 TRIAL
    Bao, M.
    Mallalieu, N. L.
    Stone, J. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 371 - 372
  • [2] Tocilizumab in patients with giant cell arteritis: results from a Phase 3 randomized controlled trial
    Mollan, Susan P.
    Tuckwell, Katie
    Dimonaco, Sophie
    Klearman, Micki
    Collinson, Neil
    Stone, John H.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [3] Pharmacokinetics and Pharmacodynamics of Tocilizumab in Combination with Prednisone Tapering in Patients with Giant Cell Arteritis: 3-Year Results from a Randomized Controlled Phase 3 Trial
    Mallalieu, Navita
    Bao, Min
    Stone, John
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [4] New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension
    Stone, John H.
    Spotswood, Helen
    Unizony, Sebastian H.
    Aringer, Martin
    Blockmans, Daniel
    Brouwer, Elisabeth
    Cid, Maria C.
    Dasgupta, Bhaskar
    Rech, Juergen
    Salvarani, Carlo
    Spiera, Robert
    Bao, Min
    RHEUMATOLOGY, 2022, 61 (07) : 2915 - 2922
  • [5] Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study
    Rule, S.
    Jurczak, W.
    Jerkeman, M.
    Rusconi, C.
    Trneny, M.
    Offner, F.
    Caballero, D.
    Joao, C.
    Witzens-Harig, M.
    Hess, G.
    Bence-Bruckler, I.
    Cho, S-G
    Thieblemont, C.
    Zhou, W.
    Henninger, T.
    Goldberg, J.
    Vermeulen, J.
    Dreyling, M.
    LEUKEMIA, 2018, 32 (08) : 1799 - 1803
  • [6] Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study
    S Rule
    W Jurczak
    M Jerkeman
    C Rusconi
    M Trneny
    F Offner
    D Caballero
    C Joao
    M Witzens-Harig
    G Hess
    I Bence-Bruckler
    S-G Cho
    C Thieblemont
    W Zhou
    T Henninger
    J Goldberg
    J Vermeulen
    M Dreyling
    Leukemia, 2018, 32 : 1799 - 1803
  • [7] Time to Flare in Patients With New-Onset Versus Relapsing Giant Cell Arteritis Treated With Tocilizumab or Placebo Plus Prednisone Tapering: 3-Year Results From a Randomized Controlled Phase 3 Trial
    Stone, John H.
    Neumann, Thomas
    Spotswood, Helen
    Unizony, Sebastian H.
    Aringer, Martin
    Blockmans, Daniel
    Brouwer, Elisabeth
    Cid, Maria C.
    Dasgupta, Bhaskar
    Rech, Juergen
    Salvarani, Carlo
    Spiera, Robert
    Bao, Min
    SWISS MEDICAL WEEKLY, 2020, : 5S - 5S
  • [8] Time to Flare in Patients with New-Onset versus Relapsing Giant Cell Arteritis Treated with Tocilizumab or Placebo Plus Prednisone Tapering: 3-Year Results from a Randomized Controlled Phase 3 Trial
    Stone, John
    Spotswood, Helen
    Unizony, Sebastian
    Aringer, Martin
    Blockmans, Daniel
    Brouwer, Elisabeth
    Cid, Maria C.
    Dasgupta, Bhaskar
    Rech, Juergen
    Salvarani, Carlo
    Spiera, Robert
    Bao, Min
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [9] Health-Related Quality of Life in Patients With Giant Cell Arteritis Treated With Tocilizumab in a Phase 3 Randomized Controlled Trial
    Haskova, Zdenka
    Strand, Vibeke
    Dimonaco, Sophie
    Tuckwell, Katie
    Klearman, Micki
    Collinson, Neil
    Stone, John H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [10] Health-Related Quality of Life in Patients with Giant Cell Arteritis Treated with Tocilizumab in a Randomized Controlled Phase 3 Trial
    Strand, Vibeke
    Dimonaco, Sophie
    Tuckwell, Katie
    Klearman, Micki
    Collinson, Neil
    Stone, John H.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
12345